Supernus Pharmaceuticals ... (SUPN)
Supernus Pharmaceuticals Max Pain By Strike
SUPN trades at $43.4, 3.3% above the near-term max pain of $42 expiring Aug 15, 2025 (0 days). Price stability likely with balanced options positioning at this level. Max pain is rising across expirations ($8-$42), reflecting growing call interest at higher strikes. Key magnetic zone at 32 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Supernus Pharmaceuticals Max Pain By Expiry
Max pain for SUPN shows an upward trend from 8 to 42, suggesting bullish positioning in longer-dated options. The 122% spread signals divergent expectations across timeframes. Most levels below 43.4 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 15, 2025 | 42 | -1.40 (-3.22%) |
| Sep 19, 2025 | 32 | -11.40 (-26.27%) |
| Oct 17, 2025 | 33 | -10.40 (-23.96%) |
| Dec 19, 2025 | 32 | -11.40 (-26.27%) |
| Jan 16, 2026 | 8 | -35.40 (-81.57%) |
| Mar 20, 2026 | 20 | -23.40 (-53.92%) |